Impact Biomedical Inc. SEC filings IBO
Impact Biomedical Inc. has 146 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 9, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 4, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Nov 6, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Oct 27, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 28, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 3, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 28, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 13, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 8, 2024 | Oct 3, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 17, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 6, 2023 | Oct 31, 2023 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Henrietta, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1834105
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.